Back
Apellis Pharmaceuticals Vs. Dyne Therapeutics Industry Stock Comparison
Sell
44
APLS
Apellis Pharmaceuticals
Last Price:
28.73
Seasonality Move:
20.78%
Buy
66
DYN
Dyne Therapeutics
Last Price:
30.60
Seasonality Move:
38.02%
Sell
44
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.23. The Score for APLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.23
The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $34.14
The current trend is relatively stagnant and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 46.19 | Sell |
Chaikin Money Flow: | -1450356 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.99 - 28.75) | Buy |
Bollinger Bands (100): | (29.38 - 39.28) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.99 | Sell |
Relative Strength Index (14 RSI): | 60.64 | Buy |
Chaikin Money Flow: | 1192325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.99 - 33.51) | Buy |
Bollinger Bands (100): | (31.49 - 42.59) | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.91 | Sell |
20-day SMA: | 28.03 | Buy |
50-day SMA: | 30.65 | Sell |
200-day SMA: | 43.67 | Sell |
8-day EMA: | 28.77 | Sell |
20-day EMA: | 28.57 | Sell |
50-day EMA: | 30.49 | Sell |
200-day EMA: | 40.29 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.58 | Buy |
20-day SMA: | 30.81 | Buy |
50-day SMA: | 32.62 | Buy |
200-day SMA: | 32.06 | Buy |
8-day EMA: | 30.24 | Buy |
20-day EMA: | 30.74 | Buy |
50-day EMA: | 32.95 | Buy |
200-day EMA: | 30.83 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.
Apellis Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |